Phase 1 Paresis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
chronic strokeStrokeIschemic Stroke+9 more
Johns Hopkins University20 enrolled1 locationNCT07053917
Recruiting
Phase 1
Thoracic Neuromodulation for Diabetic Gastroparesis
Diabetic Gastroparesis
Medical University of South Carolina48 enrolled1 locationNCT05273788
Recruiting
Phase 1
TENS in Scleroderma
SclerodermaGastroparesisSystemic Sclerosis (SSc)
University of Michigan16 enrolled1 locationNCT06646913
Recruiting
Phase 1
Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
StrokeStroke with Hemiparesis
Hasselt University12 enrolled1 locationNCT06612359